Cognition Therapeutics (CGTX) Leases (2022 - 2026)

Cognition Therapeutics (CGTX) reported Leases of $249000.0 for Q1 2026, down 43.92% year-over-year from $444000.0 in Q1 2025, and down 18.63% on a QoQ basis from $306000.0 in Q4 2025.

Cognition Therapeutics (CGTX) has 5 years of Leases data on file, last reported at $249000.0 in Q1 2026.

  • Quarterly Leases fell 43.92% year-over-year to $249000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $249000.0 (down 43.92% YoY) and the FY2025 annual result came in at $306000.0, down 38.55% from the prior year.
  • Leases fell to $249000.0 in Q1 2026 per CGTX's latest filing, from $306000.0 in the prior quarter.
  • Across five years, Leases topped out at $813000.0 in Q4 2022 and bottomed at $249000.0 in Q1 2026.
  • The 5-year median for Leases is $578000.0 (2022), against an average of $558000.0.
  • The widest annual swing landed in 2023, when Leases jumped 36.55%; it then tumbled 43.92% in 2026.
  • Tracing CGTX's Leases over 5 years: stood at $813000.0 in 2022, then slipped by 19.19% to $657000.0 in 2023, then retreated by 24.2% to $498000.0 in 2024, then tumbled by 38.55% to $306000.0 in 2025, then slipped by 18.63% to $249000.0 in 2026.
  • Per Business Quant, the three latest CGTX Leases figures stand at $249000.0 (Q1 2026), $306000.0 (Q4 2025), and $353000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Leases (Qtr)
1 Quantum Biopharma 1,638,563.89 Bn 1,638,563.89 Bn - 83,048.00
2 Alterity Therapeutics 767,934.24 Bn 767,934.20 Bn - 61,822.50
3 Legend Biotech 2,937.00 Bn 2,936.10 Bn 242.10 Mn 285.20 Mn
4 Nanobiotix 2,282.79 Bn 2,282.72 Bn - -
5 Akari Therapeutics 2,169.69 Bn 2,169.69 Bn - -
6 Vertex Pharmaceuticals 110.41 Bn 103.16 Bn 2.59 Bn 1.69 Bn
7 Regeneron Pharmaceuticals 66.44 Bn 57.69 Bn 3.31 Bn -
8 Evaxion A 65.44 Bn 65.42 Bn - -
9 Alnylam Pharmaceuticals 39.53 Bn 36.52 Bn 959.66 Mn 189.30 Mn
10 Cognition Therapeutics 648,270.00 648,270.00 - 249,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 249,000.00
Dec 31, 2025 306,000.00
Sep 30, 2025 353,000.00
Jun 30, 2025 399,000.00
Mar 31, 2025 444,000.00
Dec 31, 2024 498,000.00
Sep 30, 2024 542,000.00
Jun 30, 2024 585,000.00
Mar 31, 2024 626,000.00
Dec 31, 2023 657,000.00
Sep 30, 2023 696,000.00
Jun 30, 2023 736,000.00
Mar 31, 2023 774,000.00
Dec 31, 2022 813,000.00
Sep 30, 2022 691,000.00
Jun 30, 2022 539,000.00
Mar 31, 2022 578,000.00